IQVIA™ Real-World Insights Bibliography

A novel decision model to predict the impact of weight management interventions: The Core Obesity Model.
Author(s): Sandra Lopes 1, Henrik H Meincke 1, Mark Lamotte 2, Anamaria-Vera Olivieri 3, Michael E J Lean 4
Affiliations(s): 1Novo Nordisk A/S Søborg Denmark. 2IQVIA Zaventem Belgium. 3IQVIA Basel Switzerland. 4Human Nutrition School of Medicine, Dentistry and Nursing Royal Infirmary University of Glasgow Glasgow UK.
Publication(s):  Obesity Science & Practice 2021. https://doi.org/10.1002/osp4.495
Document Type(s): Article,
Countries: Belgium, Switzerland,
Click here for the abstract
C:
Y:
Health economics, Obesity,
2021
  L:
A:
English
Clinical setting: Primary care, Cost effectiveness,
  Add to report
 
 
Identification of potentially undiagnosed patients with nontuberculous mycobacterial lung disease using machine learning applied to primary care data in the UK
Author(s): Orla M Doyle 1 2, Roald van der Laan 3 2, Marko Obradovic 4 2, Peter McMahon 5, Flora Daniels 6, Ashley Pitcher 7, Michael R Loebinger 8
Affiliations(s): Predictive Analytics, Real World Analytical Solutions, IQVIA, London, UK. 2These authors contributed equally. 3Insmed Utrecht, Utrecht, The Netherlands. 4Insmed Utrecht, Utrecht, The Netherlands marko.obradovic@insmed.com. 5Real-World Insights, IQVIA, London, UK. 6Real-World Insights, IQVIA, Basel, Switzerland. 7Real-World Insights, IQVIA, Copenhagen, Denmark. 8Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London, UK.
Publication(s):  PMID: 32430411 DOI: 10.1183/13993003.00045-2020
Document Type(s): Article,
Countries: Switzerland, UK,
Click here for the abstract
C:
Y:
Database Validity and methodology, Pain,
2021
  L:
A:
English
Population Based Study, Real World Evidence, Retrospective database analysis,
  Add to report
 
 
Bridging the Gap Between RCTs and RWE Through Endpoint Selection
Author(s): Robert J LoCasale 1, Chris L Pashos 2, Ben Gutierrez 3, Nancy A Dreyer 4, Toby Collins 5, Alan Calleja 5, Michael J Seewald 6, Jonathan M Plumb 7, Johan Liwing 8, Maurille Feudjo Tepie 9, Sajan Khosla 10
Affiliations(s): 1Real World Evidence, Sanofi, Bridgewater, NJ, USA. 2AbbVie, Chicago, IL, USA. 3GSK, Philadelphia, PA, USA. 4IQVIA, Real-World Solutions, Cambridge, MA, USA. 5IQVIA, Real-World Solutions, London, UK. 6Novartis Pharma AG/Pharma Medical Affairs, Basel, Switzerland. 7Ferring Pharmaceuticals SA, St Prex, Switzerland. 8CellProtect Nordic Pharmaceuticals, Stockholm, Sweden. 9Center for Observational Research, Amgen, Cambridge, UK. 10Real-World Evidence Center of Excellence, AstraZeneca, Cambridge, UK. sajan.khosla@astrazeneca.com.
Publication(s):  Published online 2020 Jul 6. doi: 10.1007/s43441-020-00193-5
Document Type(s): Article,
Countries: Sweden, Switzerland, UK, USA,
Click here for the abstract
C:
Y:
Health status & patient reported outcomes,
2020
  L:
A:
English
Real World Data, Real World Evidence,
  Add to report
 
 
External Validation of the Core Obesity Model to Assess the Cost Effectiveness of Weight Management Interventions
Author(s): Sandra Lopes 1, Pierre Johansen 2, Mark Lamotte 3, Phil McEwan 4, Anamaria-Vera Olivieri 5, Volker Foos 4
Affiliations(s): 1Novo Nordisk A/S, Søborg, Denmark. snlb@novonordisk.com. 2Novo Nordisk A/S, Søborg, Denmark. 3IQVIA, Zaventem, Belgium. 4Health Economics and Outcomes Research Ltd, Cardiff, UK. 5IQVIA, Basel, Switzerland.
Publication(s):  Pharmacoeconomics 2020 https://doi.org/10.1007/s40273-020-00941-3 + Pharmacoeconomics. 2021 Jan;39(1):137-138. doi: 10.1007/s40273-020-00982-8. Epub 2020 Nov 30
Document Type(s): Article,
Countries: Belgium, Denmark, Switzerland, UK,
Click here for the abstract
C:
Y:
Health economics, Obesity,
2020
  L:
A:
English
Clinical setting: Primary care, Cost effectiveness,
  Add to report
 
 
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe
Author(s): Kotseva K1, Gerlier L2, Sidelnikov E3, Kutikova L3, Lamotte M2, Amarenco P4, Annemans L5
Affiliations(s): 1 Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, UK 2 IQVIA, Zaventem, Belgium 3 Amgen (Europe) GmbH, Rotkreuz, Switzerland 4 Department of Neurology and Stroke Centre, Bichat Hospital, Paris, France 5 University of Ghent, Belgium
Publication(s):  Eur J Prev Cardiol. 2019 Jul;26(11):1150-1157.
Document Type(s): Article,
Countries: Belgium, France, Poland, Portugal, Spain, Switzerland, UK,
Click here for the abstract
C:
Y:
Cardiovascular disease, Health economics,
2019
  L:
A:
English
Burden of illness, Clinical setting: Primary care, direct to patient research, Observational study,
  Add to report
 
 
A Survey Among Health Care Professionals to Assess Their Knowledge and Understanding on Darzalex® (Daratumumab) Educational Materials Regarding the Risk of Interference for Blood Typing in 12 European Countries
Author(s): Mathieu Rosé, Intissar Bourahla, Alessandro Ghiddi, Assem Al-Akabawi, Edmond Chan, Massoud Toussi
Affiliations(s): IQVIA, Courbevoie, France; Janssen EMEA, Medical Affairs, Italy; Janssen EMEA, Medical Affairs, UK
Publication(s):  Presented at ISPE?s 35th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE 2019), August 24?28, 2019 at the Pennsylvania Convention Center, Philadelphia, PA, USA.
Document Type(s): Poster,
Countries: Austria, Czech, Denmark, Finland, France, Germany, Hungary, Norway, Slovakia, Spain, Sweden, Switzerland,
Click here for the abstract
C:
Y:
Hematology, Oncology,
2019
  L:
A:
English
Public Health, Survey research,
  Add to report
 
 
No increased risk of spontaneous abortion and ectopic pregnancy after exposure to interferon-beta prior to or during pregnancy: Results from register-based Nordic study among women with MS
Author(s): R. Juuti1, K. M. Hakkarainen 1, S. Burkill 2, Y. Geissbuehler 3, M. Sabidó 4, C. Popescu 5, A. Adamo 6, J. Hillert 2, S. Cnattingius 2, M. Artama 7, A. Verkkoniemi-Ahola 8, K.-M. Myhr 9, J. Mehtälä 1, S. Bahmanyar 2, S. Montgomery 2,10, P. Korhonen 1 and the European Interferon Beta Pregnancy Study Group
Affiliations(s): 1StatFinn-EPID Research, Espoo, Finland
Publication(s):  EAN, Oslo, Norway, June 29-2 July, 2019
Document Type(s): Oral presentation,
Countries: Finland, Germany, Norway, Sweden, Switzerland, UK,
Click here for the abstract
C:
Y:
Neurological disorders,
2019
  L:
A:
English
Epidemiological study, Population Based Study, Retrospective database analysis,
  Add to report
 
 
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe.
Author(s): Kotseva K1, Gerlier L2, Sidelnikov E3, Kutikova L3, Lamotte M2, Annemans L4, Amarenco P5
Affiliations(s): 1 Imperial College London, London, United Kingdom 2 IQVIA, Zaventem, Belgium 3 Amgen Europe GmbH, Zug, Switzerland 4 Ghent University, Ghent, Belgium 5 Hospital Bichat-Claude Bernard, Paris, France
Publication(s):  European Society of Cardiology (ESC) Congress, 2018, Munich, Germany
Document Type(s): Poster,
Countries: Belgium, France, Poland, Portugal, Spain, Switzerland, UK,
Click here for the abstract
C:
Y:
Cardiovascular disease, Health economics,
2018
  L:
A:
English
Burden of illness, Cost of illness,
  Add to report
 
 
COMMONALITIES AND DIFFERENCES IN DATA COLLECTION ACROSS EUROPEAN SPONDYLOARTHRITIS REGISTRIES
Author(s): M. L. Hetland* 1, M. Østergaard1, J. Askling2, C. Gabay3, D. Nordstrom4, O. FitzGerald5, M. Hernández Miguel6, M. Santos7 , Z. Rotar8, H. Mann9, F. Iannone10, M. J. Nissen3, E. Hauge1, J. Gomez-Reino11, F. Díaz-González12, M. Tomsic8, K. Pavelka9, F. O'Shea5, C. Sullivan5, M. van de Sande13, I. E. van der Horst-Bruinsma13, G. J. Macfarlane14, G. T. Jones14, B. Gudbjørnsson15, T. K. Kvien16 on behalf of EuroSpA Study Group
Affiliations(s): 1DANBIO, Glostrup, Denmark, 2ARTIS, Stockholm, Sweden, 3SCQM, Geneva, Switzerland, 4ROB-FIN, Helsinki, Finland, 5ASRI, Dublin, Ireland, 6BIOBADASER, Barcelona, Spain, 7reuma.pt, Almada, Portugal, 8biorx.si, Ljubljana, Slovenia, 9ATTRA, Prague, Czech Republic, 10GISEA, Bari, Italy, 11BIOBADASER, Santiago, 12BIOBADASER, Santa Cruz de Tenerife, Spain, 13ARC, Amsterdam, Netherlands, 14BSRBR-AS, Aberdeen, United Kingdom, 15ICEBIO, Reykjavik, Iceland, 16NORDMARD, Oslo, Norway
Publication(s):  EULAR, Madrid, 2017
Document Type(s): Abstract,
Countries: Czech, Denmark, Finland, Ireland, Italy, Norway, Slovenia, Spain, Sweden, Switzerland,
Click here for the abstract
C:
Y:
Rheumatology,
2017
  L:
A:
English
Epidemiological study,
  Add to report
 
 
Rationale and design of a multi-center survey to evaluate productivity losses and indirect costs after cardiovascular events in Europe.
Author(s): Gerlier L1, Sidelnikov E2, Kutikova L2, Lamotte M1, Annemans L3
Affiliations(s): 1 QuintilesIMS, Zaventem, Belgium 2 Amgen (Europe) GmbH, Zug, Switzerland 3 University of Ghent, Ghent, Belgium
Publication(s):  19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria
Document Type(s): Abstract,
Countries: Belgium, Czech, France, Germany, Hungary, Italy, Poland, Portugal, Romania, Spain, Switzerland, UK,
C:
Y:
Cardiovascular disease,
2016
  L:
A:
English
  Add to report
 
 
 1 of 3 Next Page Last Page